163 related articles for article (PubMed ID: 7539166)
1. Paraoxonase protects against chlorpyrifos toxicity in mice.
Li WF; Furlong CE; Costa LG
Toxicol Lett; 1995 Apr; 76(3):219-26. PubMed ID: 7539166
[TBL] [Abstract][Full Text] [Related]
2. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
Li WF; Costa LG; Furlong CE
J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase and its influence on paraoxon and chlorpyrifos-oxon toxicity in rats.
Costa LG; McDonald BE; Murphy SD; Omenn GS; Richter RJ; Motulsky AG; Furlong CE
Toxicol Appl Pharmacol; 1990 Mar; 103(1):66-76. PubMed ID: 1690462
[TBL] [Abstract][Full Text] [Related]
4. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.
Cole TB; Walter BJ; Shih DM; Tward AD; Lusis AJ; Timchalk C; Richter RJ; Costa LG; Furlong CE
Pharmacogenet Genomics; 2005 Aug; 15(8):589-98. PubMed ID: 16007003
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal nematode infection increases organophosphate toxicity in rats.
Farid AS; Horii Y
Toxicol Lett; 2008 Jul; 180(1):33-7. PubMed ID: 18577432
[TBL] [Abstract][Full Text] [Related]
6. Repeated gestational exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1) modulated effects in maternal and fetal tissues.
Cole TB; Li WF; Co AL; Hay AM; MacDonald JW; Bammler TK; Farin FM; Costa LG; Furlong CE
Toxicol Sci; 2014 Oct; 141(2):409-22. PubMed ID: 25070982
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice.
Kondakala S; Lee JH; Ross MK; Howell GE
Toxicol Appl Pharmacol; 2017 Dec; 337():67-75. PubMed ID: 29097212
[TBL] [Abstract][Full Text] [Related]
8. Interactive toxicity of the organophosphorus insecticides chlorpyrifos and methyl parathion in adult rats.
Karanth S; Liu J; Olivier K; Pope C
Toxicol Appl Pharmacol; 2004 Apr; 196(2):183-90. PubMed ID: 15081265
[TBL] [Abstract][Full Text] [Related]
9. The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
Liu J; Pope C
Neurotoxicology; 2015 Jan; 46():12-8. PubMed ID: 25447325
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
11. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
12. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
13. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase.
Furlong CE; Richter RJ; Seidel SL; Costa LG; Motulsky AG
Anal Biochem; 1989 Aug; 180(2):242-7. PubMed ID: 2479288
[TBL] [Abstract][Full Text] [Related]
14. Interactive toxicity of chlorpyrifos and parathion in neonatal rats: role of esterases in exposure sequence-dependent toxicity.
Kacham R; Karanth S; Baireddy P; Liu J; Pope C
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):142-9. PubMed ID: 16260018
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicologically relevant concentrations.
Sogorb MA; García-Argüelles S; Carrera V; Vilanova E
Chem Res Toxicol; 2008 Aug; 21(8):1524-9. PubMed ID: 18597495
[TBL] [Abstract][Full Text] [Related]
16. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
Kropp TJ; Richardson RJ
J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
[TBL] [Abstract][Full Text] [Related]
17. The PON1 gene and detoxication.
Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis.
Shih DM; Gu L; Xia YR; Navab M; Li WF; Hama S; Castellani LW; Furlong CE; Costa LG; Fogelman AM; Lusis AJ
Nature; 1998 Jul; 394(6690):284-7. PubMed ID: 9685159
[TBL] [Abstract][Full Text] [Related]
19. In vivo interaction between chlorpyrifos and parathion in adult rats: sequence of administration can markedly influence toxic outcome.
Karanth S; Olivier K; Liu J; Pope C
Toxicol Appl Pharmacol; 2001 Dec; 177(3):247-55. PubMed ID: 11749124
[TBL] [Abstract][Full Text] [Related]
20. Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.
Cole TB; Beyer RP; Bammler TK; Park SS; Farin FM; Costa LG; Furlong CE
Toxicol Sci; 2011 Sep; 123(1):155-69. PubMed ID: 21673326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
